Phase 1 trial study of 131 I-labeled chimeric 81 C 6 monoclonal antibody for the treatment of patients with non-Hodgkin lymphoma
暂无分享,去创建一个
J. Bowsher | R. Coleman | D. Bigner | C. Decastro | S. Clayton | M. Zalutsky | D. Rizzieri | S. Metzler | N. Chao | Joseph O. Moore | J. Gockerman | A. Lagoo | G. Akabani | C. Gasparetto | C. Pegram | Bonnie Toaso | Elizabeth Anderson | J. Moore